Pain in Inflammatory Joint Diseases

Not yet recruitingOBSERVATIONAL

Enrollment

350

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions

ArthritisArthritis, Juvenile IdiopathicArthritis,RheumatoidArthritis, ReactiveArthritis, PsoriaticSpondyloarthritis (SpA)

Interventions

DRUG

Biological or targeted synthetic DMARD

All biological or targeted synthetic DMARDs that are available for treatment of patients with inflammatory joint diseases

All Listed Sponsors

collaborator

University of Oslo

OTHER

lead

Diakonhjemmet Hospital

OTHER

NCT06718569 - Pain in Inflammatory Joint Diseases | Biotech Hunter | Biotech Hunter